panitumumab  - Removal Estimates

💊 panitumumab 

panitumumab  Dialyzability By Different Modalities

MW: 144324.12
Protein Binding: N/A
Vd: 0.042 L/kg

📊 Removal Estimates

Estimates based on drug properties and standard treatment parameters.

🩸

Hemodialysis

32.4 mL/min
Poorly Dialyzable
Minimal removal expected. Half-life: 9.4 days (range: 4-11 days). No supplementation needed. Despite long half-life, clearance is low due to other factors.
Data Used:
✅ molar_mass, mw_factor, vd, vd_factor, half_life
⚠️ Missing: protein_binding
Free fraction: 0.5 Mw factor: 0.2 Vd factor: 1 Hl factor: 1.2 Half life: 9.4 days (range: 4-11 days) Half life category: Extended (> 72h)
🫀

Peritoneal Dialysis

0.2 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 9.4 days (range: 4-11 days).
Data Used:
✅ molar_mass, half_life
⚠️ Missing: protein_binding
Free fraction: 0.5 Half life: 9.4 days (range: 4-11 days) Half life category: Extended (> 72h)
🔄

Plasmapheresis (TPE)

Unable to Assess
Insufficient data for TPE risk assessment. Protein binding and Vd required.
Data Used:
✅ vd, half_life
⚠️ Missing: protein_binding
Half life: 9.4 days (range: 4-11 days) Half life category: Extended (> 72h)
🧪

Hemoadsorption

High Effectiveness
Excellent candidate for hemoperfusion. Long half-life suggests significant removal possible. Effective in overdose. Rebound expected.
Data Used:
✅ vd, half_life
Half life: 9.4 days (range: 4-11 days) Half life category: Extended (> 72h)

📋 Summary of Estimates

Modality Clearance/Value Half-Life Classification Data Quality
Hemodialysis 32.4 mL/min 9.4 days (range: 4-11 days) Poorly Dialyzable Partial Data
Peritoneal Dialysis 0.2 mL/min 9.4 days (range: 4-11 days) Low PD Clearance Partial Data
Plasmapheresis (TPE) Unable to Assess 9.4 days (range: 4-11 days) N/A Partial Data
Hemoadsorption High Effectiveness 9.4 days (range: 4-11 days) N/A Complete Data

📌 Important Notes

Back to Drug Details